Publication|Articles|May 27, 2026
Supplements and Featured Publications
- Alopecia Areata: Clinical Evidence and Managed Care Insights for FDA-Approved JAK Inhibitors
Alopecia Areata: Clinical Evidence and Managed Care Insights for FDA-Approved JAK Inhibitors
Advertisement
This publication was sponsored by Sun Pharmaceutical Industries, Inc.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
3
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5